Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 151 AL 165

Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease

Pugazhenthi S.

Prog Mol Biol Transl Sci. 2017;146:243-258. doi: 10.1016/bs.pmbts.2016.12.016. Epub 2017 Feb 4.

Mitochondria, Cybrids, Aging, and Alzheimer's Disease

Swerdlow RH, Koppel S, Weidling I, Hayley C, Ji Y, Wilkins HM.

Prog Mol Biol Transl Sci. 2017;146:259-302. doi: 10.1016/bs.pmbts.2016.12.017. Epub 2017 Feb 1.

Mitochondrial Perturbation in Alzheimer's Disease and Diabetes

Akhter F, Chen D, Yan SF, Yan SS.

Prog Mol Biol Transl Sci. 2017;146:341-361. doi: 10.1016/bs.pmbts.2016.12.019. Epub 2017 Feb 4.

Aquaporins in Nervous System

Xu M, Xiao M, Li S, Yang B.

Adv Exp Med Biol. 2017;969:81-103. doi: 10.1007/978-94-024-1057-0_5.

Role of neuroinflammation in neurodegeneration: new insights

McManus RM, Heneka MT.

Alzheimers Res Ther. 2017 Mar 4;9(1):14. doi: 10.1186/s13195-017-0241-2.

Clinically Relevant Drug Interactions with Anti-Alzheimer's Drugs

Caraci F, Sultana J, Drago F, Spina E.

CNS Neurol Disord Drug Targets. 2017;16(4):501-513. doi: 10.2174/1871527316666170303144817.

Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe?

Griffin JW, Bradshaw PC.

Oxid Med Cell Longev. 2017;2017:5472792. doi: 10.1155/2017/5472792. Epub 2017 Feb 5.

Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease

Takahashi RH, Nagao T, Gouras GK.

Pathol Int. 2017 Apr;67(4):185-193. doi: 10.1111/pin.12520. Epub 2017 Mar 5.

The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: A European Alzheimer's Disease Consortium study

Bosco P, Redolfi A, Bocchetta M, Ferrari C, Mega A, Galluzzi S, Austin M, Chincarini A, Collins DL, Duchesne S, Maréchal B, Roche A, Sensi F, Wolz R, Alegret M, Assal F, Balasa M, Bastin C, Bougea A, Emek-Savaş DD, Engelborghs S, Grimmer T, Grosu G, Kramberger MG, Lawlor B, Mandic Stojmenovic G, Marinescu M, Mecocci P, Molinuevo JL, Morais R, Niemantsverdriet E, Nobili F, Ntovas K, O'Dwyer S, Paraskevas GP, Pelini L, Picco A, Salmon E, Santana I, Sotolongo-Grau O, Spiru L, Stefanova E, Popovic KS, Tsolaki M, Yener GG, Zekry D, Frisoni GB.

Alzheimers Dement. 2017 Sep;13(9):1013-1023. doi: 10.1016/j.jalz.2017.01.019. Epub 2017 Mar 3.

Therapeutic potential of nuclear receptor agonists in Alzheimer's disease

Moutinho M, Landreth GE.

J Lipid Res. 2017 Oct;58(10):1937-1949. doi: 10.1194/jlr.R075556. Epub 2017 Mar 6.

Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts

Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J.

J Neural Transm (Vienna). 2017 Jun;124(6):671-683. doi: 10.1007/s00702-017-1702-2. Epub 2017 Mar 6.

Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection

Brandt R, Bakota L.

J Neurochem. 2017 Nov;143(4):409-417. doi: 10.1111/jnc.14011. Epub 2017 Apr 19.

Alzheimer's Disease: Characterization of the Brain Sites of the Initial Tau Cytoskeletal Pathology Will Improve the Success of Novel Immunological Anti-Tau Treatment Approaches

Rüb U, Stratmann K, Heinsen H, Seidel K, Bouzrou M, Korf HW.

J Alzheimers Dis. 2017;57(3):683-696. doi: 10.3233/JAD-161102.

A Novel PSEN1 K311R Mutation Discovered in Chinese Families with Late-Onset Alzheimer's Disease Affects Amyloid-β Production and Tau Phosphorylation

Dong J, Qin W, Wei C, Tang Y, Wang Q, Jia J.

J Alzheimers Dis. 2017;57(2):613-623. doi: 10.3233/JAD-161188.

Islet amyloid polypeptide: Another key molecule in Alzheimer's pathogenesis?

Zhang Y, Song W.

Prog Neurobiol. 2017 Jun;153:100-120. doi: 10.1016/j.pneurobio.2017.03.001. Epub 2017 Mar 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias